These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Experimental thymitis, myocarditis and polymyositis. A contribution to the pathogenesis of myasthenia gravis Erb]. Griss P; Fahr K Arch Kreislaufforsch; 1970; 63(3):257-65. PubMed ID: 4928860 [No Abstract] [Full Text] [Related]
26. [Animal model of myasthenia gravis--with special reference to Goldstein's autoimmune thymitis]. Yonezawa T Nihon Rinsho; 1972 Jan; 30(1):160-3. PubMed ID: 4556867 [No Abstract] [Full Text] [Related]
27. [Thymoma--lymphocyte production and immunologic abnormality]. Tamaoki N Nihon Rinsho; 1977; 35(10):3712-7. PubMed ID: 342746 [No Abstract] [Full Text] [Related]
28. Muscle pathology, thymoma, and immunological abnormalities in patients with myasthenia gravis. Oosterhuis HJ; Bethlem J; Feltkamp TE J Neurol Neurosurg Psychiatry; 1968 Oct; 31(5):460-3. PubMed ID: 4885252 [No Abstract] [Full Text] [Related]
29. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis. Mygland A; Aarli JA; Matre R; Gilhus NE J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674 [TBL] [Abstract][Full Text] [Related]
30. IgG subclass distribution of myasthenia gravis thymoma-associated antiskeletal muscle antibodies. Smith CI; Aarli JA; Hammarström L; Persson MA Neurology; 1984 Aug; 34(8):1094-6. PubMed ID: 6540388 [TBL] [Abstract][Full Text] [Related]
31. Pathophysiology and immunological profile of myasthenia gravis and its subgroups. Romi F; Hong Y; Gilhus NE Curr Opin Immunol; 2017 Dec; 49():9-13. PubMed ID: 28780294 [TBL] [Abstract][Full Text] [Related]
32. Thymic lymphocytes in myasthenia gravis. Birnbaum G; Tsairis P Ann Neurol; 1977 Apr; 1(4):331-3. PubMed ID: 152595 [TBL] [Abstract][Full Text] [Related]
33. Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis. Cuénoud S; Feltkamp TE; Fulpius BW; Oosterhuis HJ Neurology; 1980 Feb; 30(2):201-2. PubMed ID: 7188802 [TBL] [Abstract][Full Text] [Related]
34. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Lindstrom JM; Seybold ME; Lennon VA; Whittingham S; Duane DD Neurology; 1976 Nov; 26(11):1054-9. PubMed ID: 988512 [TBL] [Abstract][Full Text] [Related]
35. Anti-titin antibodies are not associated with a specific thymoma histology. Voltz R; Albrich W; Hohlfeld R; Nagel D; Wick M; Kirchner T; Sommer N; Illa I; Kaminski H; Schumm F J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):282. PubMed ID: 12531976 [No Abstract] [Full Text] [Related]
36. [Immunofluorescence studies in myasthenia]. Slomkowska H Neurol Neurochir Pol; 1972; 6(2):205-10. PubMed ID: 4555306 [No Abstract] [Full Text] [Related]
37. Clinical and biological heterogeneity of autoimmune myasthenia gravis. Pal J; Rozsa C; Komoly S; Illes Z J Neuroimmunol; 2011 Feb; 231(1-2):43-54. PubMed ID: 21093931 [TBL] [Abstract][Full Text] [Related]
38. Lymphocyte subpopulations in thymus and blood from patients with myasthenia gravis. Aarli JA; Heimann P; Matre R; Thunold S; Tönder O J Neurol Neurosurg Psychiatry; 1979 Jan; 42(1):29-34. PubMed ID: 310870 [TBL] [Abstract][Full Text] [Related]
39. Editorial: Cause of weakness in myasthenia gravis. Grob D N Engl J Med; 1976 Mar; 294(13):722-3. PubMed ID: 1082544 [No Abstract] [Full Text] [Related]